| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V69527 | [Tyr0] Gastric Inhibitory Peptide (23-42), human | 121765-67-1 | [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak gastric acid secretion inhibitor and can also stimulate insulin secretion. |
|
V128390 | Aganirsen sodium scrambled negative control | The Aganirsen sodium scrambled negative control is a negative control with the sequence of Aganirsen sodium scrambled. | |
|
V112389 | Centpiperalone | 22587-11-7 | Semperaprone is an effective oral hypoglycemic agent. |
|
V76983 | GIP (1-30) amide, porcine TFA | GIP (1-30) amide, porcine TFA is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist/activator with the same affinity as native GIP (1-42). | |
|
V85951 | human GIP(3-30), amide | 1884226-05-4 | |
|
V69513 | Insulin degludec | 844439-96-9 | Insulin degludec is an ultra-long-acting form of insulin used to study the hyperglycemia caused by type 1 and type 2 diabetes. |
|
V69528 | Insulin peglispro (BIL) | 1200440-65-8 | Insulin peglispro (BIL) is a basal insulin with a flat, prolonged activity profile. |
|
V139276 | Macupatide | 2923558-68-1 | Macupatide is a glucose-dependent insulinotropic peptide (GIP) receptor agonist. |
|
V146986 | Visepegenatide | 2641081-54-9 | Visepegenatide is a polyethylene glycol-modified exenatide. |
|
V147197 | XOMA 129 | XOMA 129 is a human monoclonal antibody that targets the insulin receptor (INSR). | |
|
V147285 | Z971169476 | 1356662-88-8 | Z971169476 is a sulfonamide protein-RNA interaction inhibitor that targets the KH34 region of insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2/IMP2). |
|
V147312 | Zenagamtide | 3005889-81-3 | Zenagamtide is an orally effective, blood-brain barrier-crossing triple agonist that targets GLP-1, amylin (amylin receptor), and calcitonin receptor (calcitonin receptor). |
|
V1940 | MSDC-0160 (Mitoglitazone; CAY-10415) | 146062-49-9 | Mitoglitazone (MSDC-0160; CAY10415), a thiazolidinedione analog,is the prototypical mTOT(mitochondrial target of thiazolidinediones)-modulating insulin sensitizer being investigated to treat diabetes and Alzheimers disease. |